Register Interest
Registration for 3rd Allogeneic Cell Therapies Summit Europe is now closed.
Thank you to our Speakers, Sponsors & Delegates for joining us!
Register your interest to be the first to hear updates about the 2024 meeting.
Join Your Peers at the Next Meeting in the Allogeneic Cell Therapy Series:
Cell Therapy
Delivering Safer, More Effective & Globally Accessible Cell Therapies to Patients at Scale
Conferences
Our Cell Therapy conferences aim to supercharge durable, safe, and cost-effective cell therapies for patients. We focus on helping overcome the discovery, translational, clinical, and commercial hurdles to realize cell therapies for patients at scale.
Data
Beacon's cell therapy database covers trial and drug records for preclinical, active, approved, and discontinued CAR (chimeric antigen receptor) modified therapies, TCR (T-Cell Receptor) therapies, natural killer cells, tumor-infiltrating lymphocytes cytokine-induced killer cells, dendritic cells, and macrophages.
Research
A trusted provider of market intelligence for anyone looking to understand the complexities of cell therapy research and development.